TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2822.
Locate Jan Aushadhi KendraClinical Overview
Diazepam and Imipramine combines a classical long-acting benzodiazepine with a tricyclic antidepressant (TCA). Imipramine blocks reuptake of norepinephrine and serotonin to treat depression, while diazepam immediately quells panic, anxiety, motor agitation, and insomnia. Indicated for depression accompanied by pronounced anxiety, agitation, or sleep architecture disruption.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with water, preferably at bedtime, with or without food. Follow strict titration schedules. Taper slowly when discontinuing.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Sedation, dry mouth, blurred vision, constipation, urinary retention, postural hypotension, ataxia. Rare/Severe: Cardiac arrhythmias, seizures, severe respiratory depression, dependence, and suicidality.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated during acute recovery from myocardial infarction and with MAOIs. Extreme caution in elderly patients, glaucoma, and prostate enlargement. Avoid alcohol.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Diazepam Tablets 5 mg
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Diazepam Injection 5mg per ml
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.
Imipramine Hydrochloride Tablets 25mg
Imipramine Hydrochloride is a dibenzazepine derivative tricyclic antidepressant on the WHO Model List of Essential Medicines. It blocks the presynaptic reuptake of norepinephrine and serotonin. It is metabolized into desipramine, an active selective norepinephrine reuptake inhibitor. Indicated for major depressive disorder, panic disorder, and nocturnal enuresis in pediatric patients aged 6 years and older.
Diazepam Tablets 2 mg
Diazepam is a prototype long-acting 1,4-benzodiazepine on the WHO Model List of Essential Medicines. It binds to the GABAA receptor complex in the limbic system, thalamus, and hypothalamus, facilitating GABA-mediated inhibitory neurotransmission. Possesses an active desmethyldiazepam metabolite with a prolonged elimination half-life (up to 100 hours). Indicated for management of anxiety disorders, acute alcohol withdrawal syndrome (delirium tremens), skeletal muscle spasm, and status epilepticus.